Armin Frille

Dr. Armin Frille

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Breathe
Verified
Journal Article
Open access
PDF file
GHGEORGIA HARDAVELLA
GEORGIA HARDAVELLA
IKIoannis Karampinis
Ioannis Karampinis
AFArmin Frille
Armin Frille
KSKatherina Sreter
Katherina Sreter
IRIlona Rousalova
Ilona Rousalova
Oxygen use has extended from inpatient to outpatient settings for patients with chronic pulmonary diseases and complications of hypoxaemia. This article presents an overview of oxygen devices (oxygen concentrators, compressed gas cylinders and liquid oxygen) and delivery systems (high- and low-flow). The indications, advantages and disadvantages of each device and delivery system are presented, aiming to offer updated knowledge to the multidisciplinary team members managing patients with respiratory failure, and therefore allowing appropriate selection of devices and delivery systems that are tailored to the needs of each patient.

8 June 2017 in Breathe
Verified
Journal Article
Open access
PDF file
GHGEORGIA HARDAVELLA
GEORGIA HARDAVELLA
AAAne Aamli-Gaagnat
Ane Aamli-Gaagnat
AFArmin Frille
Armin Frille
NSNeil Saad
Neil Saad
ANAlexandra Niculescu
Alexandra Niculescu
PPPippa Powell
Pippa Powell
When challenging situations arise in doctor–patient interactions, how can we best manage them?http://ow.ly/J1GI30bD5wp

1 December 2020 in Breathe
Verified
Journal Article
Open access
PDF file
GHGEORGIA HARDAVELLA
GEORGIA HARDAVELLA
AFArmin Frille
Armin Frille
CTChristina Theochari
Christina Theochari
EKElli Keramida
Elli Keramida
EBElena Bellou
Elena Bellou
IKIoannis Karampinis
Ioannis Karampinis
Multidisciplinary care is the cornerstone of lung cancer treatment in the developed world, even though there is a relative lack of consistent evidence that this care model improves outcomes. In this review, we present the available literature regarding how to set up and run an efficient multidisciplinary care model for lung cancer patients with emphasis on team members’ roles and responsibilities. Moreover, we present some limited evidence about multidisciplinary care and its impact on lung cancer outcomes and survival.This review provides simple guidance on setting up and running a multidisciplinary service for lung cancer patients. It highlights the importance of defined roles and responsibilities for team members. It also presents concise information based on the literature regarding the impact of multidisciplinary care in lung cancer outcomes (e.g.survival of patients undergoing lung cancer surgery).

17 October 2022 in Translational Oncology
Verified
Journal Article
Open access
HKHartmut Kuhn
Hartmut Kuhn
AFArmin Frille
Armin Frille
MPMarie Anna Petersen
Marie Anna Petersen
JOJonas Oberhuber-Kurth
Jonas Oberhuber-Kurth
LHLukas Hofmann
Lukas Hofmann
HWHubert Wirtz
Hubert Wirtz
• IGFBP3 inhibits lung cancer cell spheroid growth (3D proliferation). • IGFBP3 inhibits invasion by reduction of MMP activity. • Higher IGFBP3 plasma levels correlates with a less aggressive tumor. • Increased plasma levels is associated with improved overall cancer patient survival.

1 June 2024 in Breathe
Verified
Journal Article
Open access
PDF file
GHGEORGIA HARDAVELLA
GEORGIA HARDAVELLA
AFArmin Frille
Armin Frille
KSKatherina Bernadette Sreter
Katherina Bernadette Sreter
FAFlorence Atrafi
Florence Atrafi
UYUraujh Yousaf-Khan
Uraujh Yousaf-Khan
SJSam M. Janes
Sam M. Janes
Lung cancer screening (LCS) programmes have emerged over recent years around the world. LCS programmes present differences in delivery, inclusion criteria and resource allocation. On a national scale, only a few LCS programmes have been fully established, but more are anticipated to follow. Evidence has shown that, in combination with a low-dose chest computed tomography scan, smoking cessation should be offered as part of a LCS programme for improved patient outcomes. Promising tools in LCS include further refined risk prediction models, the use of biomarkers, artificial intelligence and radiomics. However, these tools require further study and clinical validation is required prior to routine implementation.

29 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
MHMario Hönemann
Mario Hönemann
STStephanie Thiem
Stephanie Thiem
SBSandra Bergs
Sandra Bergs
TBTom Berthold
Tom Berthold
CPChristian Propach
Christian Propach
CPCorinna Pietsch
Corinna Pietsch
Following the extensive non-pharmaceutical interventions (NPIs) and behavioral changes in the wake of the SARS-CoV-2 pandemic, an interseasonal rise in respiratory syncytial virus (RSV) cases was observed in Germany in 2021. The aim of this study was to characterize the local molecular epidemiology of RSV infections in comparison to the three pre-pandemic seasons. Additionally, clinical data were retrieved from patient charts to determine the clinical significance of RSV infections. RSV detections peaked in calendar week 40 of 2021, 18 weeks earlier than the usual peak observed in the three pre-pandemic seasons. Sequence analysis revealed a close phylogenetic relatedness regardless of the season of origin. A significantly higher amount of pediatric cases (88.9% of all cases, p < 0.001) was observed for season 2021/2022. For the pediatric cases, significant differences were observed for an increased number of siblings in the household (p = 0.004), a lower rate of fever (p = 0.007), and a reduced amount of co-infections (p = 0.001). Although the mean age of the adult patients was significantly younger (47.1 vs. 64.7, p < 0.001), high rates of comorbidities, lower respiratory tract infections and intensive care unit admissions prevailed. The NPIs in the wake of the SARS-CoV-2 pandemic had a tremendous impact on the epidemiologic characteristics and seasonality of RSV and warrant further epidemiologic studies of this important pathogen.